BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$9.11
-0.14 (-1.51%)
âŧ
5d:
+3.17%
30d:
-0.33%
90d:
-45.45%
WAIT
LOW Confidence
Analysis Updated: Aug 20, 2026 12:00 AM ET
Earnings: Sep 14, 2026
23d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BNR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BNR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $9.11, which is considered slightly low relative to its 30-day fair value range of $8.83 to $9.97.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.81, while resistance sits at $11.27.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.81, while resistance sits at $11.27.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$8.83 -
$9.97
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 56.4% above Wall St target ($4.03)
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.83 -
$9.97
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$8.81
Resistance Level
$11.27
Current Trend
Strong Downtrend
Technical data as of
Aug 20, 2026
Fundamental Context
Wall Street Target
$4.03
(-56.4%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: August 21, 2026 11:30 AM ET
Data refreshes hourly during market hours. Next update: 12:30 PM
Data refreshes hourly during market hours. Next update: 12:30 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 43 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
